Agneta Nordberg

Research interests

Publications

• Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

  JAMA Neurology · 2024 · https://doi.org/10.1001/jamaneurol.2024.3770

• Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

  The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00066-1

• Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

  The Lancet Neurology · 2020 · https://doi.org/10.1016/s1474-4422(20)30314-8

• Astrocyte Biomarkers in Alzheimer’s Disease

  Trends in Molecular Medicine · 2019 · https://doi.org/10.1016/j.molmed.2018.11.006

• Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30159-x

• Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

  JAMA Psychiatry · 2017 · https://doi.org/10.1001/jamapsychiatry.2017.3391

• Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

  Brain · 2016 · https://doi.org/10.1093/brain/aww160

• Defeating Alzheimer's disease and other dementias: a priority for European science and society

  The Lancet Neurology · 2016 · https://doi.org/10.1016/s1474-4422(16)00062-4

• SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

  Journal of Nuclear Medicine · 2016 · https://doi.org/10.2967/jnumed.116.174615

• Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

  Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.09.009

• Mild cognitive impairment with suspected nonamyloid pathology (SNAP)

  Neurology · 2015 · https://doi.org/10.1212/wnl.0000000000001209

• Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.4668

• Prevalence of Amyloid PET Positivity in Dementia Syndromes

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.4669

• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

  The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0

• A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

  European Journal of Nuclear Medicine and Molecular Imaging · 2012 · https://doi.org/10.1007/s00259-012-2237-2

• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  Annals of Neurology · 2004 · https://doi.org/10.1002/ana.20009

• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  Journal of Internal Medicine · 2004 · https://doi.org/10.1111/j.1365-2796.2004.01380.x

• Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease

  Dementia and Geriatric Cognitive Disorders · 1999 · https://doi.org/10.1159/000017196

Current projects

No projects listed.